Memorandum of Understanding Signed: Ireland Takes a Significant Step Towards Strengthening Collaboration with EATRIS-ERIC

Published 21 November 2023


The Trinity Translational Medicine Institute (TTMI) of Trinity College Dublin, Ireland, and the European Infrastructure for Translational Medicine (EATRIS-ERIC) are pleased to announce the signing of a Memorandum of Understanding (MoU) that marks a major milestone towards Ireland’s potential prospective membership in EATRIS-ERIC.

The MoU formalises the commitment of both parties to foster collaboration and coordination in promoting the benefits of Ireland’s potential membership in EATRIS-ERIC among national research institutions through the Translational Medicine Alliance Ireland. The agreement encompasses various activities aimed at enhancing translational research capabilities, developing academia-industry partnerships and driving progress in the field.

Anne-Charlotte Fauvel (Head of EU Affairs at EATRIS) expressed her enthusiasm for the MoU, stating: “This MoU represents a significant step forward in our mission to advance translational research across Europe. We are excited to collaborate with the Trinity Translational Medicine Institute and are confident that this partnership will contribute greatly to the growth and success of translational medicine in Ireland. Ultimately, it is patients that will benefit.”

Professor Aideen Long (Director at TTMI) added: “This is a great opportunity for Ireland to enhance its translational research capabilities. This MoU underscores our commitment to strengthening the Irish scientific community’s engagement in translational research and personalised medicine at European level.”

Both parties look forward to a productive and fruitful collaboration that will benefit the Irish scientific community and contribute to EATRIS-ERIC’s mission. As part of this collaboration, TTMI will host the launch event of the Translational Medicine Alliance Ireland on 1st December 2023 in Dublin.


EATRIS is the European infrastructure for translational medicine that brings together resources and services for research communities to translate scientific discoveries into benefits for patients. The organisation is a non-profit that provides access to a vast array of expertise and facilities from over 150 top-tier academic centres across Europe. EATRIS focuses on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcoming barriers to health innovation.

About the Trinity Translational Medicine Institute

TTMI is located the grounds of St James’s Hospital, the largest acute general hospital in Ireland. The research focus of the institute is in translational medicine with an emphasis on patient-orientated research facilitating collaboration between clinicians, scientists and the biomed/biopharma industry. TTMI’s remit extends across St James’s, Tallaght University Hospital, Our Lady’s Hospital for Sick Children (Children’s Health Ireland) and the Coombe Women and Children’s Hospitals, creating the new Trinity Translational Development Pathway, based on international best practice. The substantive co-operative Institute currently houses approximately 50 principal investigators (PI’s) and 160 research scientists working under research themes that include Infection and Immunity, Cancer, Genomics of Disease and Nanomedicine. The location of TTMI within the acute hospital setting, enhances the study of a broad spectrum of disease states underpinned by collaborations with fundamental, translational, and clinical research practitioners and Biobank/patient accessibility. The close proximity of the Wellcome Trust – HRB Clinical Research Facility enables the expedient translation of clinical research breakthroughs into opportunities for regulated clinical trials.

About Translational Medicine Alliance Ireland 

Translational Medicine Alliance Ireland (TMAI) is a new initiative organised as a decentralised collaborative network of 10 Irish Universities to include Technological Universities with the aim of boosting engagement and collaboration in translational research within and outside the network. It will be a platform to target EU funding opportunities and to foster industry- academia partnerships. The formation of TMAI is an important milestone in our journey to join EATRIS-ERIC, an organisation that supports translational research activities.  Maximising the potential benefits of EU funding with the support and leadership of EATRIS-ERIC will further our capacity in the development of new healthcare therapeutics, products, and services to benefit the health and economy of Ireland.

For general inquiries, please contact:

For media inquiries, please contact: